Lifecore Biomedical, Inc. De (LFCR) Cost of Revenue (2010 - 2025)

Lifecore Biomedical's Cost of Revenue history runs 16 years deep, the most recent figure standing at $22.5 million for Q2 2025.

• In Q2 2025, Cost of Revenue rose 8.96% year-over-year to $22.5 million; the TTM figure through May 2025 stood at $88.6 million (up 2.5% YoY), while the FY2025 annual figure was $88.6 million, up 2.5% from the prior year.
• Cost of Revenue was $22.5 million for Q2 2025 at Lifecore Biomedical, down from $25.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $25.3 million in Q1 2025 to a low of -$30.1 million in Q2 2021.
• Historically, Cost of Revenue has averaged $17.2 million across 5 years, with a median of $19.8 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue tumbled 87.3% in 2021, then soared 158.65% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $14.1 million in 2021, then rose by 14.44% to $16.2 million in 2022, then increased by 24.76% to $20.2 million in 2023, then increased by 6.37% to $21.5 million in 2024, then advanced by 4.57% to $22.5 million in 2025.
• The last three Cost of Revenue figures came in at $22.5 million (Q2 2025), $25.3 million (Q1 2025), and $21.5 million (Q4 2024), per Business Quant data.